GSK Factory in Tianjin Affected by Explosion
GSK reports no employee injuries at the facility and is assessing damage.
A GlaxoSmithKline factory located in Tianjin, China-near the site of an Aug. 12, 2015 warehouse explosion-was affected but no employees were injured, according to a company statement. The company has two facilities in the area.
The statement reports that the company has taken “urgent measures to ensure the safety of employees and their families, and to assess plant damage.”
GlaxoSmithKline (Tianjin) Co., Ltd. and American Tianjin Smith Kline Pharmaceutical Co., Ltd. will jointly donate one million yuan ($156,00) to the China Red Cross and is ready to provide any drugs for the recovery effort, the statement reports.
The explosion in an industrial area of the port city has claimed more than 100 lives, with more than 100 people listed as missing.
Source: GSK China (requires translation)
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
